Mutant mouse models and their contribution to our knowledge of corpus luteum development, function and regression

Reproductive Biology and Endocrinology

Volumn 1, Issue , 2003, Pages

  Henkes, Luiz E ^a   Davis, John S ^b,c   Rueda, Bo R ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c VA NEBRASKA WESTERN IOWA HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; PROGESTERONE;

AUTOCRINE EFFECT; CELL PROLIFERATION; CELL TYPE; CORPUS LUTEUM FUNCTION; ENDOCRINE FUNCTION; ESTRUS CYCLE; FEMALE; GENE FUNCTION; GRANULOSA CELL; IN VITRO STUDY; IN VIVO STUDY; LUTEAL INSUFFICIENCY; LUTEINIZATION; LUTEOLYSIS; MOUSE; MOUSE MUTANT; NONHUMAN; OVARY FOLLICLE DEVELOPMENT; OVULATION; PARACRINE SIGNALING; PROGESTERONE SYNTHESIS; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; CONGENITAL MALFORMATION; CORPUS LUTEUM; DISEASE MODEL; GENETICS; GROWTH, DEVELOPMENT AND AGING; MUTATION; PHYSIOLOGY; PRENATAL DEVELOPMENT;

ANIMALS; CORPUS LUTEUM; DISEASE MODELS, ANIMAL; FEMALE; MICE; MUTATION;

EID: 4344712899     PISSN: 14777827     EISSN: None     Source Type: Journal    
DOI: 10.1186/1477-7827-1-87     Document Type: Review

References (80)

1. Davis JS, Rueda BR: The corpus luteum: an ovarian structure with maternal instincts and suicidal tendencies. Front Biosci 2002, 7:d1949-1978.
2. Niswender GD, Juengel JL, Silva PJ, Rollyson MK, McIntush EW: Mechanisms controlling the function and life span of the corpus luteum. Physiol Rev 2000, 80:1-29.
3. McCracken JA, Custer EE, Lamsa JC: Luteolysis: a neuroendocrine-mediated event. Physiol Rev 1999, 79:263-323.
4. Cavicchio VA, Pru JK, Davis BS, Davis JS, Rueda BR, Townson DH: Secretion of monocyte chemoattractant protein-1 (MCP-1) by endothelial cells of the bovine corpus luteum: Regulation by cytokines but not prostaglandin F2 alpha. Endocrinology 2002, 143:3582-3589.
5. Pru JK, Lynch MP, Davis JS, Rueda BR: Signaling mechanisms in tumor necrosis factor alpha-induced death of microvascular endothelial cells of the corpus luteum. Reprod Biol Endocrinol 2003, 1:17.
6. Danilovich N, Babu PS, Xing W, Gerdes M, Krishnamurthy H, Sairam MR: Estrogen deficiency, obesity, and skeletal abnormalities in follicle-stimulating hormone receptor knockout (FORKO) female mice. Endocrinology 2000, 141:4295-4308.
7. Burns KH, Yan C, Kumar TR, Matzuk MM: Analysis of ovarian gene expression in follicle-stimulating hormone beta knockout mice. Endocrinology 2001, 142:2742-2751.
8. Kendall SK, Samuelson LC, Saunders TL, Wood RI, Camper SA: Targeted disruption of the pituitary glycoprotein hormone alpha-subunit produces hypogonadal and hypothyroid mice. Genes Dev 1995, 9:2007-2019.
9. Couse JF, Korach KS: Reproductive phenotypes in the estrogen receptor-alpha knockout mouse. Ann Endocrinol (Paris) 1999, 60:143-148.
10. Couse JF, Korach KS: Estrogen receptor null mice: what have we learned and where will they lead us? Endocr Rev 1999, 20:358-417.
11. Lydon JP, DeMayo FJ, Conneely OM, O'Malley BW: Reproductive phenotpes of the progesterone receptor null mutant mouse. J Steroid Biochem Mol Biol 1996, 56:67-77.
12. Sicinski P, Donaher JL, Geng Y, Parker SB, Gardner H, Park MY, Robker RL, Richards JS, McGinnis LK, et al.: Cyclin D2 is an FSH-responsive gene involved in gonadal cell proliferation and oncogenesis. Nature 1996, 384:470-474.
13. Fero ML, Rivkin M, Tasch M, Porter P, Carow CE, Firpo E, Polyak K, Tsai LH, Broudy V, Perlmutter RM, et al.: A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice. Cell 1996, 85:733-744.
14. Fisher CR, Graves KH, Parlow AF, Simpson ER: Characterization of mice deficient in aromatase (ArKO) because of targeted disruption of the cyp19 gene. Proc Natl Acad Sci U S A 1998, 95:6965-6970.
15. Lim H, Paria BC, Das SK, Dinchuk JE, Langenbach R, Trzaskos JM, Dey SK: Multiple female reproductive failures in cyclooxygenase 2-deficient mice. Cell 1997, 91:197-208.
16. Robker RL, Richards JS: Hormone-induced proliferation and differentiation of granulosa cells: a coordinated balance of the cell cycle regulators cyclin D2 and p27Kip1. Mol Endocrinol 1998, 12:924-940.
17. Jin SL, Richard FJ, Kuo WP, D'Ercole AJ, Conti M: Impaired growth and fertility of cAMP-specific phosphodiesterase PDE4D-deficient mice. Proc Natl Acad Sci U S A 1999, 96:11998-12003.
18. White R, Leonardsson G, Rosewell I, Ann Jacobs M, Milligan S, Parker M: The nuclear receptor co-repressor nrip1 (RIP140) is essential for female fertility. Nat Med 2000, 6:1368-1374.
19. Simon AM, Goodenough DA, Li E, Paul DL: Female infertility in mice lacking connexin 37. Nature 1997, 385:525-529.
20. Drazen DL, Klein SL, Burnett AL, Wallach EE, Crone JK, Huang PL, Nelson RJ: Reproductive function in female mice lacking the gene for endothelial nitric oxide synthase. Nitric Oxide 1999, 3:366-374.
21. Jablonka-Shariff A, Olson LM: The role of nitric oxide in oocyte meiotic maturation and ovulation: meiotic abnormalities of endothelial nitric oxide synthase knock-out mouse oocytes. Endocrinology 1998, 139:2944-2954.
22. Chappell PE, Lydon JP, Conneely OM, O'Malley BW, Levine JE: Endocrine defects in mice carrying a null mutation for the progesterone receptor gene. Endocrinology 1997, 138:4147-4152.
23. Mulac-Jericevic B, Mullinax RA, DeMayo FJ, Lydon JP, Conneely OM: Subgroup of reproductive functions of progesterone mediated by progesterone receptor-B isoform. Science 2000, 289:1751-1754.
24. Drummond AE, Findlay JK: The role of estrogen in folliculogenesis. Mol Cell Endocrinol 1999, 151:57-64.
25. Britt KL, Findlay JK: Estrogen actions in the ovary revisited. J Endocrinol 2002, 175:269-276.
26. Drummond AE, Britt KL, Dyson M, Jones ME, Kerr JB, O'Donnell L, Simpson ER, Findlay JK: Ovarian steroid receptors and their role in ovarian function. Mol Cell Endocrinol 2002, 191:27-33.
27. Green S, Walter P, Greene G, Krust A, Goffin C, Jensen E, Scrace G, Waterfield M, Chambon P: Cloning of the human oestrogen receptor cDNA. J Steroid Biochem 1986, 24:77-83.
28. Green S, Walter P, Kumar V, Krust A, Bornert JM, Argos P, Chambon P: Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A. Nature 1986, 320:134-139.
29. Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JA: Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci U S A 1996, 93:5925-5930.
30. Couse JF, Hewitt SC, Bunch DO, Sar M, Walker VR, Davis BJ, Korach KS: Postnatal sex reversal of the ovaries in mice lacking estrogen receptors alpha and beta. Science 1999, 286:2328-2331.
31. Dufau ML: The luteinizing hormone receptor. Annu Rev Physiol 1998, 60:461-496.
32. Hillier SG: Gonadotropic control of ovarian follicular growth and development. Mol Cell Endocrinol 2001, 179:39-46.
33. Ziecik AJ, Derecka-Reszka K, Rzucidlo SJ: Extragonadal gonadotropin receptors, their distribution and function. J Physiol Pharmacol 1992, 43:33-49.
34. Zhang M, Shi H, Segaloff DL, Van Voorhis BJ, Zheng M: Expression and localization of luteinizing hormone receptor in the female mouse reproductive tract. Biol Reprod 2001, 64:179-187.
35. Jameson JL: Inherited disorders of the gonadotropin hormones. Mol Cell Endocrinol 1996, 125:143-149.
36. Huhtaniemi I: The Parkes lecture. Mutations of gonadotrophin and gonadotrophin receptor genes: what do they teach us about reproductive physiology? J Reprod Fertil 2000, 119:173-186.
37. Themmen APN, Huhtaniemi IT: Mutations of gonadotropins and gonadotropin receptors: elucidating the physiology and pathophysiology of pituitary-gonadal function. Endocr Rev 2000, 21:551-583.
38. Lei ZM, Mishra S, Zou W, Xu B, Foltz M, Li X, Rao CV: Targeted disruption of luteinizing hormone/human chorionic gonadotropin receptor gene. Mol Endocrinol 2001, 15:184-200.
39. Rao CV, Lei ZM: Consequences of targeted inactivation of LH receptors. Mol Cell Endocrinol 2002, 187:57-67.
40. Huhtaniemi I, Zhang FP, Kero J, Hamalainen T, Poutanen M: Transgenic and knockout mouse models for the study of luteinizing hormone and luteinizing hormone receptor function. Mol Cell Endocrinol 2002, 187:49-56.
41. Zhang FP, Poutanen M, Wilbertz J, Huhtaniemi I: Normal prenatal but arrested postnatal sexual development of luteinizing hormone receptor knockout (LuRKO) mice. Mol Endocrinol 2001, 15:172-183.
42. Sterneck E, Tessarollo L, Johnson PF: An essential role for C/EBPbeta in female reproduction. Genes Dev 1997, 11:2153-2162.
43. St John MA, Tao W, Fei X, Fukumoto R, Carcangiu ML, Brownstein DG, Parlow AF, McGrath J, Xu T: Mice deficient of Lats1 develop soft-tissue sarcomas, ovarian tumours and pituitary dysfunction. Nat Genet 1999, 21:182-186.
44. Sherr CJ: The Pezcoller lecture: cancer cell cycles revisited. Cancer Res 2000, 60:3689-3695.
45. Richards JS, Russell DL, Robker RL, Dajee M, Alliston TN: Molecular mechanisms of ovulation and luteinization. Mol Cell Endocrinol 1998, 145:47-54.
46. Tong W, Kiyokawa H, Soos TJ, Park MS, Soares VC, Manova K, Pollard JW, Koff A: The absence of p27Kip1, an inhibitor of G1 cyclin-dependent kinases, uncouples differentiation and growth arrest during the granulosa->luteal transition. Cell Growth Differ 1998, 9:787-794.
47. Moons DS, Jirawatnotai S, Tsutsui T, Franks R, Parlow AF, Hales DB, Gibori G, Fazleabas AT, Kiyokawa H: Intact follicular maturation and defective luteal function in mice deficient for cyclin-dependent kinase-4. Endocrinology 2002, 143:647-654.
48. Rane SG, Dubus P, Mettus RV, Galbreath EJ, Boden G, Reddy EP, Barbacid M: Loss of Cdk4 expression causes insulin-deficient diabetes and Cdk4 activation results in beta-islet cell hyperplasia. Nat Genet 1999, 22:44-52.
49. Stein SA, Oates EL, Hall CR, Grumbles RM, Fernandez LM, Taylor NA, Puett D, Jin S: Identification of a point mutation in the thyrotropin receptor of the hyt/hyt hypothyroid mouse. Mol Endocrinol 1994, 8:129-138.
50. Jiang JY, Imai Y, Umezu M, Sato E: Characteristics of infertility in female hypothyroid (hyt) mice. Reproduction 2001, 122:695-700.
51. Nothnick WB: Tissue inhibitor of metalloproteinase-1 (TIMP-1) deficient mice display reduced serum progesterone levels during corpus luteum development. Endocrinology 2003, 144:5-8.
52. Risk M, Gibori G: Mechanisms of luteal cell regulation by prolactin Boston: Kluwer Academic Publishers 2001.
53. Bowen JM, PL, Warren JS, Townson DH: Prolactin-induced regression of the rat corpus luteum: expression of monocyte chemoattractant protein-1 and invasion of macrophages. Biol Reprod 1996, 54:1120-1127.
54. Grosdemouge I, Bachelot A, Lucas A, Baran N, Kelly PA, Binart N: Effects of deletion of the prolactin receptor on ovarian gene expression. Reprod Biol Endocrinol 2003, 1:12.
55. Bazer FW: Mediators of maternal recognition of pregnancy in mammals. Proc Soc Exp Biol Med 1992, 199:373-384.
56. Morita I: Distinct functions of COX-1 and COX-2. Prostaglandins Other Lipid Mediat 2002, 68-69:165-175.
57. Langenbach R, Morham SG, Tiano HF, Loftin CD, Ghanayem BI, Chulada PC, Mahler JF, Lee CA, Goulding EH, Kluckman KD, et al.: Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration. Cell 1995, 83:483-492.
58. Gross GA, Imamura T, Luedke C, Vogt SK, Olson LM, Nelson DM, Sadovsky Y, Muglia LJ: Opposing actions of prostaglandins and oxytocin determine the onset of murine labor. Proc Natl Acad Sci U S A 1998, 95:11875-11879.
59. Sugimoto Y, Yamasaki A, Segi E, Tsuboi K, Aze Y, Nishimura T, Oida H, Yoshida N, Tanaka T, Katsuyama M, Hasumoto K, Murata T, Hirata M, Ushikubi F, Negishi M, Ichikawa A, Narumiya S: Failure of parturition in mice lacking the prostaglandin F receptor. Science 1997, 277:681-683.
60. Sugimoto Y, Segi E, Tsuboi K, Ichikawa A, Narumiya S: Female reproduction in mice lacking the prostaglandin F receptor. Roles of prostaglandin and oxytocin receptors in parturition. Adv Exp Med Biol 1998, 449:317-321.
61. Reese J, Zhao X, Ma WG, Brown N, Maziasz TJ, Dey SK: Comparative analysis of pharmacologic and/or genetic disruption of cyclooxygenase-1 and cyclooxygenase-2 function in female reproduction in mice. Endocrinology 2001, 142:3198-3206.
62. Ivell R, Bathgate RA: Reproductive biology of the relaxin-like factor (RLF/INSL3). Biol Reprod 2002, 67:699-705.
63. Irving-Rodgers HF, Bathgate RA, Ivell R, Domagalski R, Rodgers RJ: Dynamic changes in the expression of relaxin-like factor (INSL3), cholesterol side-chain cleavage cytochrome p450, and 3beta-hydroxysteroid dehydrogenase in bovine ovarian follicles during growth and atresia. Biol Reprod 2002, 66:934-943.
64. Spanel-Borowski K, Schafer I, Zimmermann S, Engel W, Adham IM: Increase in final stages of follicular atresia and premature decay of corpora lutea in Insl3-deficient mice. Mol Reprod Dev 2001, 58:281-286.
65. Pate JL, Landis Keyes P: Immune cells in the corpus luteum: friends or foes? Reproduction 2001, 122:665-676.
66. Pate JL: Involvement of immune cells in regulation of ovarian function. J Reprod Fertil Suppl 1995, 49:365-377.
67. Roby KF, Son DS, Terranova PF: Alterations of events related to ovarian function in tumor necrosis factor receptor type I knockout mice. Biol Reprod 1999, 61:1616-1621.
68. Bukovsky A, Presl J, Krabec Z, Bednarik T: Ovarian function in adult rats treated with antithymocyte serum. Experientia 1977, 33:280-281.
69. Nagata S: Human autoimmune lymphoproliferative syndrome, a defect in the apoptosis-inducing Fas receptor: a lesson from the mouse model. J Hum Genet 1998, 43:2-8.
70. Takahashi T, Tanaka M, Brannan CI, Jenkins NA, Copeland NG, Suda T, Nagata S: Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 1994, 76:969-976.
71. Sakamaki K, Yoshida H, Nishimura Y, Nishikawa S, Manabe N, Yonehara S: Involvement of Fas antigen in ovarian follicular atresia and luteolysis. Mol Reprod Dev 1997, 47:11-18.
72. MAPK. Endocrinology 2002, 143:4350-4357.
73. Quirk SM, Harman RM, Huber SC, Cowan RG: Responsiveness of mouse corpora luteal cells to Fas antigen (CD95)-mediated apoptosis. Biol Reprod 2000, 63:49-56.
74. Quirk SM, Cowan RG, Joshi SG, Henrikson KP: Fas antigen-mediated apoptosis in human granulosa/luteal cells. Biol Reprod 1995, 52:279-287.
75. Roughton SA, Lareu RR, Bittles AH, Dharmarajan AM: Fas and Fas ligand messenger ribonucleic acid and protein expression in the rat corpus luteum during apoptosis-mediated luteolysis. Biol Reprod 1999, 60:797-804.
76. Carambula SF, Pru JK, Lynch MP, Matikainen T, Goncalves PB, Flavell RA, Tilly JL, Rueda BR: Prostaglandin F2alpha- and FAS-activating antibody-induced regression of the corpus luteum involves caspase-8 and is defective in caspase-3 deficient mice. Reprod Biol Endocrinol 2003, 1:15.
77. Carambula SF, Matikainen T, Lynch MP, Flavell RA, Goncalves PB, Tilly JL, Rueda BR: Caspase-3 is a pivotal mediator of apoptosis during regression of the ovarian corpus luteum. Endocrinology 2002, 143:1495-1501.
78. Robker RL, Richards JS: Hormonal control of the cell cycle in ovarian cells: proliferation versus differentiation. Biol Reprod 1998, 59:476-482.
79. Krege JH, Hodgin JB, Couse JF, Enmark E, Warner M, Mahler JF, Sar M, Korach KS, Gustafsson JA, Smithies O: Generation and reproductive phenotypes of mice lacking estrogen receptor beta. Proc Natl Acad Sci U S A 1998, 95:15677-15682.
80. Rao CV, Alsip NL: Use of the rat model to study hCG/LH effects on uterine blood flow. Semin Reprod Med 2001, 19:75-85.